BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19799362)

  • 1. [Genomic damage, adaptive response induction in blood lymphocytes at the prostate cancer patients. Connection with the tumour radiotherapy efficiency].
    Pelevina II; Aleshchenko AV; Antoshchina MM; Kudriashova OV; Lizunova EIu; Minaeva NG; Osipov AN; Parshkov EM; Riabchenko NI; Sviridov PV; Semenova LP; Serebrianyĭ AM
    Radiats Biol Radioecol; 2009; 49(4):419-24. PubMed ID: 19799362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are the properties of peripheral blood lymphocytes of patients with prostate cancer connected with the efficiency of radiation therapy?].
    Pelevina II; Aleshchenko AV; Antoshhina MM; Biriukov VA; Kariakin OB; Kudriashova OV; Nikonova MF; Minaeva NG; Serebrianyĭ AM; Iarilin AA
    Radiats Biol Radioecol; 2014; 54(3):273-82. PubMed ID: 25764831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular-biological properties of blood lymphocytes of Hodgkin's lymphoma patients. Plausible possibility of treatment effect prognosis].
    Pelevina II; Aleshchenko AV; Antoshchina MM; Vorob'eva NIu; Kudriashova OV; Lashkova OE; Lizunova EIu; Osipov AN; Riabchenko NI; Serebrianyĭ AM; Pavlov VV
    Radiats Biol Radioecol; 2012; 52(2):142-8. PubMed ID: 22690576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adaptive response in the different mitotic cycles after irradiation].
    Pelevina II; Aleshchenko AV; Antoshchina MM; Boeva OV; Gotlib VIa; Kudriashova OV; Lizunova EIu; Osipov AN; Riabchenko NI; Semenova LP; Serebrianyĭ AM
    Tsitologiia; 2009; 51(1):78-83. PubMed ID: 19281051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The radiosensitivity change of human blood lymphocytes in different mitotic cycles after a low dose irradiation].
    Serebrianyĭ AM; Aleshchenko AV; Antoshchina MM; Kudriashova OV; Riabchenko NI; Semenova LP; Pelevina II
    Radiats Biol Radioecol; 2008; 48(6):713-20. PubMed ID: 19178049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An individual variability of the adaptive response to irradiation in human cells. Approach to its determination].
    Pelevina II; Aleshchenko AA; Antoshchina MM; Riabchenko NI; Semenova LP; Serebrianyĭ AM
    Radiats Biol Radioecol; 2007; 47(6):658-66. PubMed ID: 18380324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the new mechanism of adaptive response].
    Serebrianyĭ AM; Aleshchenko AV; Gotlib VIa; Kudriashova OV; Semenova LP; Pelevina II
    Radiats Biol Radioecol; 2004; 44(6):653-6. PubMed ID: 15700804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetic results of irradiation of Southern Ural residents].
    Akleev AV; Aleshchenko AV; Antoshchina MM; Gotlib VIa; Kudriashova OV; Semenova LP; Serebrianyĭ AM; Khudiakova OI; Pelevina II
    Radiats Biol Radioecol; 2002; 42(6):696-9. PubMed ID: 12530154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity.
    Lee TK; Allison RR; O'Brien KF; Johnke RM; Christie KI; Naves JL; Kovacs CJ; Arastu H; Karlsson UL
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):222-9. PubMed ID: 12909237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double-strand DNA breaks induction and repair in human blood lymphocytes irradiated with adapting dose].
    Osipov AN; Lizunova EIu; Vorob'eva NIu; Pelevina II
    Radiats Biol Radioecol; 2009; 49(1):42-5. PubMed ID: 19368320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cytogenetic damage, radiosensitivity and adaptive response in children living in the different districts of Moscow].
    Pelevina II; Aleshchenko AV; Gotlib VIa; Kudriashova OV; Kurneshova LE; Noskin LA; Semenova LP; Serebrianyĭ AM
    Radiats Biol Radioecol; 2004; 44(3):278-82. PubMed ID: 15287257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response for radiation-induced apoptosis, residual 53BP1 foci and DNA-loop relaxation in human lymphocytes.
    Torudd J; Protopopova M; Sarimov R; Nygren J; Eriksson S; Marková E; Chovanec M; Selivanova G; Belyaev IY
    Int J Radiat Biol; 2005 Feb; 81(2):125-38. PubMed ID: 16019922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
    Zebentout O; Apardian R; Beaulieu L; Harel F; Martin AG; Vigneault E
    Cancer Radiother; 2010 Jun; 14(3):183-8. PubMed ID: 20418145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronuclei in lymphocytes of prostate cancer patients undergoing radiation therapy.
    Lee TK; O'Brien KF; Naves JL; Christie KI; Arastu HH; Eaves GS; Wiley AL; Karlsson UL; Salehpour MR
    Mutat Res; 2000 Aug; 469(1):63-70. PubMed ID: 10946243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in cellular radiosensitivity after low dose irradiation].
    Pelevina II; Aleshchenko AV; Antoshchina MM; Kudriashova OV; Riabchenko NI; Akleev AV
    Radiats Biol Radioecol; 2012; 52(5):481-6. PubMed ID: 23227711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.